{"id":58383,"date":"2023-11-09T04:02:24","date_gmt":"2023-11-09T03:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/"},"modified":"2023-11-09T04:02:24","modified_gmt":"2023-11-09T03:02:24","slug":"gilead-sciences-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"Gilead Sciences to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p>FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/GILD?src=hash\" target=\"_blank\" rel=\"noopener\">#GILD<\/a>&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/5\/GCP_Primarylarge_1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/5\/GCP_Primarylarge_1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/22\/GCP_Primarylarge_1.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nJefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time<\/li>\n<li>\nEvercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time<\/li>\n<li>\nPiper Sandler Healthcare Conference on Wednesday, November 29 at 9:00am Eastern Time<\/li>\n<\/ul>\n<p>\nThe live webcasts can be accessed at the company\u2019s investors page at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finvestors.gilead.com&amp;esheet=53796656&amp;newsitemid=20231108938335&amp;lan=en-US&amp;anchor=investors.gilead.com&amp;index=1&amp;md5=7b8373f6636dd4b5debe38e8f46b1d27\" rel=\"nofollow noopener\" shape=\"rect\">investors.gilead.com<\/a>. The replays will be available for at least 30 days following the presentation.<\/p>\n<p>\n<b><span class=\"bwuline\">About Gilead Sciences<\/span><\/b><\/p>\n<p>\nGilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.<\/p>\n<p>\n<i>For more information on Gilead Sciences, please visit the company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gilead.com&amp;esheet=53796656&amp;newsitemid=20231108938335&amp;lan=en-US&amp;anchor=www.gilead.com&amp;index=2&amp;md5=4e73914acb417b797d5c2a2e56737b21\" rel=\"nofollow noopener\" shape=\"rect\">www.gilead.com<\/a>, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.<\/i><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJacquie Ross, CFA \u2013 Investors<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#105;n&#x76;&#101;s&#x74;&#111;r&#x5f;&#114;e&#x6c;&#97;t&#x69;&#111;n&#x73;&#64;g&#x69;&#108;e&#x61;&#100;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x6e;&#118;&#x65;&#115;&#x74;&#111;&#x72;_&#x72;e&#x6c;a&#x74;i&#111;&#x6e;&#115;&#x40;&#103;&#x69;&#108;&#x65;&#97;&#x64;&#46;&#x63;o&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;#GILD&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: Jefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time Evercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time Piper Sandler Healthcare Conference on Wednesday, November 29 at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58383","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gilead Sciences to Present at Upcoming Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead Sciences to Present at Upcoming Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;#GILD&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: Jefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time Evercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time Piper Sandler Healthcare Conference on Wednesday, November 29 at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-09T03:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gilead Sciences to Present at Upcoming Investor Conferences\",\"datePublished\":\"2023-11-09T03:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/\"},\"wordCount\":205,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231108938335\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/\",\"name\":\"Gilead Sciences to Present at Upcoming Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231108938335\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"datePublished\":\"2023-11-09T03:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231108938335\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231108938335\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead Sciences to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead Sciences to Present at Upcoming Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Gilead Sciences to Present at Upcoming Investor Conferences - Pharma Trend","og_description":"FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;#GILD&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: Jefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time Evercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time Piper Sandler Healthcare Conference on Wednesday, November 29 at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2023-11-09T03:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gilead Sciences to Present at Upcoming Investor Conferences","datePublished":"2023-11-09T03:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/"},"wordCount":205,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/","name":"Gilead Sciences to Present at Upcoming Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg","datePublished":"2023-11-09T03:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231108938335\/en\/778437\/21\/GCP_Primarylarge_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gilead Sciences to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58383"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58383\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}